Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad39c5cf2c048525ad7cf78aee724ee2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_358308ad18fb570cf08e949465bffd70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f888a89bfe18cb0be7e87fb38492207e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce644e7696f3a749f9cc30a17b48f09a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06 |
filingDate |
2011-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79508281f92a7e196918cd6b3d901fd6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93f79bda20dc53354f5bf22e43b9f251 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53b9aaf3075683c93c59a94a23e65f4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_060e7b4bc165bc8f9cc5e3a23fe15cec |
publicationDate |
2015-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9206154-B2 |
titleOfInvention |
Inverse agonists and neutral antagonists for the TSH receptor |
abstract |
TSHR inverse agonists and neutral antagonists that are useful for treating Graves' orbitopathy, Graves' hyperthyroidism and/or thyroid cancer. |
priorityDate |
2010-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |